The Mexico infection control market is projected to grow at a compound annual growth rate of 3.77% over the forecast period to attain a market size of US$175.357 million in 2027, from US$135.319 million in 2020. Mexico's market for infection control is anticipated to have a sizable market share over the forecast period. The country's booming medical tourism industry is blamed for the expansion. One of the most popular places for people to travel for medical and dental procedures is Mexico. As a result, the market for infection control has a great chance of growing during the future years.
Furthermore, with a rapidly declining fertility rate, the country’s geriatric population is expected to triple by 2050. Hence, this is also a major driver for the infection control market to grow in the forecast period and the upcoming years. The United Nations estimates that the population aged 65 years and older is estimated to grow by 277% to achieve a population size of more than 30 million from a population of 8.2 million in 2015, at the end of 2050. From 2.27 births per woman in 2013 to 2.157 births per woman in 2017, the country's fertility rate decreased (source: The World Bank).
The nation's numerous manufacturing sectors are fueling the market's demand for infection control.
Mexico is home to many big manufacturing industries, which will continue to grow in the forecast period and in the coming years. This is because the country’s large and diverse labor population continues to expand throughout every industry here. Also, the growing labor charges and transportation inflation in China further augment the manufacturing industry’s growth. Hence, these will require infection control products to maintain the health and hygiene of the working personnel in the manufacturing industry. The prominent industries in the country include automotive, aerospace and aviation, medical device, and textile and consumer goods, fueling the market demand. Additionally, the highly skilled workforce in Mexico is further contributing to the market growth where they are well-aware of cross-contamination in various industrial areas, especially in the laboratories.
In the anticipated time, the prevalence of people with chronic illnesses is fueling market demand.
In Mexico, there is a presence of people who are suffering from non-communicable chronic diseases. The main ones include lipid diseases, diabetes, hypertension, and obesity. Hence, this leads to continuous patient visits to hospitals for frequent patient monitoring and care for infection prevention. This is because these patients have a greater susceptibility to infections. Hence, the hospitals, clinics, and other medical facilities require proper infection prevention and control to protect from disease-causing microorganisms the patients and the caretakers, thereby burgeoning the market growth in the forecast period.
COVID-19 SCENARIO
The need for sterilisation and disinfection in hospitals and clinics has increased during COVID-19. There have also been technological advances in sterilisation and disinfection equipment, a surge in the outsourcing of sterilisation services by hospitals, pharmaceutical, and medical device companies, and an increase in the production of single-use products and medical nonwovens. The COVID 19 outbreak has caused a sharp rise in demand for infection control products, which has significantly impacted the expansion of the infection control market in Mexico. The market for infection control is likely to rise, but it will be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed devices. On the other hand, during the forecast period, increased use of single-use medical nonwovens and devices is anticipated to present profitable prospects.
Key Development
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2020 | US$135.319 million |
| Market Size Value in 2027 | US$175.357 million |
| Growth Rate | CAGR of 3.77% from 2020 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2022–2027 |
| Forecast Unit (Value) | USD Million |
| Segments Covered | Product And End User Industry |
| Companies Covered | 3M, Medtronic, STERIS plc, Cantel Medical, Ecolab |
| Customization Scope | Free report customization with purchase |
Segmentation: